Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP vs SAP Block for Pain After Total Mastectomy
NCT03619447Phase 4
Key facts
- Status
- Unknown
- Start
- Sep 2018
- Primary completion
- Mar 2019
- Sponsor
- Cukurova University
- Modality
- Small Molecules
- Drugs
- bupivacainelidocaine
- Conditions
- postoperative pain
01
Overview
Phase 4, randomised trial of bupivacaine and lidocaine in postoperative pain, sponsored by Cukurova University. Primary endpoint: Total morphine consumption at 24 hours. Status: unknown.
02
Design
- Study design
- Randomized
03
Who it enrols
Patients aged 18-65 with ASA I-II status undergoing total mastectomy.
04
Endpoints
Primary
Total morphine consumption
Secondary
Numerical Rating Scale
Beyond the preview
Go deeper on NCT03619447.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03619447.